Disordered cellular immunity in type 1 diabetes of man and the BB rat

  • John B. Buse
  • Richard F. Rowley
  • George S. Eisenbarth


Beta Cell Bete Spontaneous Diabetes Suppressor Cell Activity Streptozotocin Induce Diabetes Mellitus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Rotter, J.I.; Rimoin, D.L.: Genetics; in Brownlee, Diabetes mellitus, vol. 1: etiology, hormone physiology, pp. 3–93 (Garland, New York 1981).Google Scholar
  2. 2.
    Volpe, R.: Monographs on endocrinology, vol. 20: Autoimmunity in the endocrine system (Springer, New York 1981).Google Scholar
  3. 3.
    Kahn, C.R.; Baird, K.L.; Flier, J.S.; Grunfeld, C.; Harmon, J.T.; Harrison, L.C.; Karlsson, F.A.; Kasuga, M.; King, G.L.; Lang, U.C.; Podskalny, J.M.; Obberghen, E.V.: Insulin receptors, receptor antibodies and the mechanism of insulin action. Recent Prog. Horm. Res.37: 477–533 (1981).PubMedGoogle Scholar
  4. 4.
    Cahill, G.F., Jr.; McDevitt, H.O.: Insulin-dependent diabetes mellitus: the initial lesion. New Engl. J. Med.304: 1454–1465 (1981).PubMedGoogle Scholar
  5. 5.
    Handwerger, B.S.; Fernandes, G.; Brown, D.M.: Immune and autoimmune aspects of diabetes mellitus. Human Pathol.11: 338–352 (1980).CrossRefGoogle Scholar
  6. 6.
    Selam, J.L.; Clot, J.; Andary, M.; Mirouze, J.: Circulating lymphocyte subpopulations in juvenile insulin-dependent diabetes. Diabetologia16: 35–40 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    Ptak, W.; Hanczakowska, M.; Rozycka, R.; Rozycka, D.: Impaired antibody responses in alloxan diabetic mice. Clin. exp. Immunol.29: 140–146 (1977).PubMedGoogle Scholar
  8. 8.
    Ptak, W.; Rewicka, M.; Kollat, M.: Development of specific suppressor cells in hypoinsulinaemic mice. Nature283: 199–200 (1980).PubMedCrossRefGoogle Scholar
  9. 9.
    Ptak, W.; Rewicka, M.; Kollat, M.; Walicki, W.: Ease of induction of cells producing TNP-specific suppressor factor in hypoinsulinemic mice. Clin. Immunol. Immunopathol.19: 447–451 (1981).PubMedCrossRefGoogle Scholar
  10. 10.
    Roth, M.D.; Barg, M.; Michalski, R.; Arquilla, E.R.: Cell-mediated immunity in chronically diabetic mice. Diabetes29: 825–829 (1980).PubMedGoogle Scholar
  11. 11.
    Bersani, G.; Zanco, P.; Padovan, D.; Betterle, C.: Lymphocyte subpopulations in insulin-dependent diabetics with and without serum islet-cell autoan-tibodies. Diabetologia20: 47–50 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    Jackson, R.; Rassi, N.; Crump, T.; Haynes, B.; Eisenbarth, G.S.: The BB diabetic rat. Profound T-cell lymphocytopenia. Diabetes30: 887–889 (1981).PubMedCrossRefGoogle Scholar
  13. 13.
    Poussier, P.; Nakhooda, A.F.; Falk, J.A.; Lee, C; Marliss, E.B.: Lymphopenia and abnormal lymphocyte subsets in the ‘BB’ rat: relationship to the diabetic syndrome. Endocrinology110: 1825–1827 (1982).PubMedGoogle Scholar
  14. 14.
    Elder, M.; MacLaren, N.: Immunoincompetence in the BB rat (Abstract). Diabetes31: suppl. 2, p. 48 (1982).Google Scholar
  15. 15.
    Nakhooda, A.F.; Like, A.A.; Chappel, C.I.; Murray, F.T.; Marliss, E.B.: The spontaneously diabetic Wistar rat. Metabolic and morphologic studies. Diabetes26: 100–112 (1976).CrossRefGoogle Scholar
  16. 16.
    Like, A.A.; Butler, L.; Williams, R.M.; Appel, M.C.; Weringer, E.J.; Rossini, A.A.: Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes31: suppl. 1. pp. 7–13 (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    Marliss, E.B.; Sima, A.A.F.; Nakhooda, A.F.: Spontaneous diabetes in the ‘BB’ Wistar rat; in Martin, Ehrlich, Holland, Etiology and pathogenesis of insulin dependent diabetes mellitus, pp. 251–274 (Raven Press, New York 1981).Google Scholar
  18. 18.
    Tannenbaum, G.S.; Colle, E.; Gurd, W.; Wana-maker, L.: Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. I. Longitu- dinal profiles of plasma growth hormone, insulin, and glucose. Endocrinology109: 1872–1879 (1981).PubMedGoogle Scholar
  19. 19.
    Tannenbaum, G.S.; Colle, E.; Wanamaker, L.; Gurd, W.; Goldman, H.; Seemayer, T.A.: Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. II. Insulin-, glucagon-, and somatostatin-reactive cells in the pancreas. Endocrinology109: 1880–1887 (1981).PubMedCrossRefGoogle Scholar
  20. 20.
    Nakhooda, A.F.; Like, A.A.; Chappel, C.I.; Wei, C.-N.; Marliss, E.B.: The spontaneously diabetic Wistar rat (the ‘BB’ rat). Studies prior to and during development of the overt syndrome. Diabetologia14: 199–207 (1978).PubMedCrossRefGoogle Scholar
  21. 21.
    Rossini, A.A.; Williams, R.M.; Mordes, J.P.; Appel, M.C.; Like, A.A.: Spontaneous diabetes in the gnotobiotic BB/W rat. Diabetes28: 1031–1032 (1979).PubMedCrossRefGoogle Scholar
  22. 22.
    Rossini, A.A.; Mordes, J.P.; Williams, R.M.; Like, A.A.: Expression of diabetes in Bio-Breeding/Worcester (BB/W) rats is not influenced by diet (Abstract). Diabetes30: suppl. 1, p. 93 (1981).Google Scholar
  23. 23.
    Elder, M.; McLaren, N.; Riley, W.; McConnell, T.: Gastric parietal cell and other autoantibodies in the BB rat. Diabetes31: 313–318 (1982).PubMedCrossRefGoogle Scholar
  24. 24.
    Sternthal, E.; Like, A.A.; Sarantis, K.; Braverman, L.E.: Lymphocytic thyroiditis and diabetes in the BB/W rat. A new model of autoimmune endocrinopathy. Diabetes30: 1058–1061 (1981).PubMedCrossRefGoogle Scholar
  25. 25.
    Eisenbarth, G.; Jackson, R.: Immunogenetics of polyglandular failure and related disease; in Farid, HLA in endocrine and metabolic disorders (Academic Press, New York 1981).Google Scholar
  26. 26.
    Dobersen, M.J.: Humoral autoimmunity in insulin-dependent (type I) diabetes mellitus. A current assessment. Surv. immunol. Res.1: 329–338 (1982).PubMedGoogle Scholar
  27. 27.
    Dyrberg, T.; Nakhooda, A.F.; Baekkeskov, S.; Lernmark, A.; Poussier, P.; Marliss, E.B.: Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes31: 278–281 (1982).PubMedCrossRefGoogle Scholar
  28. 28.
    Dyrberg, T.; Nakhooda, A.F.; Baekkeskov, S.; Poussier, P.; Marliss, E.B.; Lernmark, A.: Islet cell surface antibodies (ICSA) and lymphocyte antibodies (LA) in the spontaneously diabetic BB Wistar rat (Abstract). Diabetes31: suppl. 2, p. 19 (1982).Google Scholar
  29. 29.
    Naji, A.; Silvers, W.; Bellgrau, D.; Barker, C.: Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science213: 1390–1392 (1981).PubMedCrossRefGoogle Scholar
  30. 30.
    Like. A.; Rossini, A.; Guberski, D.; Appel, M.: Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science206: 1421–1423 (1979).PubMedCrossRefGoogle Scholar
  31. 31.
    Like, A.; Kislauskis, E.; Williams, R.; Rossini, A.: Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat. Science216: 644–646(1982).PubMedCrossRefGoogle Scholar
  32. 32.
    Naji, A.; Silvers, W.K.; Barker, C.F.: Islet transplantation in spontaneously diabetic rats. Transplant. Proc.13: 826–828 (1981).PubMedGoogle Scholar
  33. 33.
    Kadison, P.: Jackson, R.; Rassi, N.; Haynes, B.; Jegasothy, B.; Eisenbarth, G.S.: The BB rat: selective W3/25 T cell lymphocytopenia and profound depression of mitogen responsiveness (Abstract). Clin. Res.30: 396 (1982).Google Scholar
  34. 34.
    Jackson, R.: Buse, J.B.; Eisenbarth, G.S.: Unpublished observations.Google Scholar
  35. 35.
    Haynes, B.: Warren, R.; Buckley, R.; McClure, J.; Goldstein, A.; Eisenbarth, G.S.: Complex ganglio-sides as markers of thymic epithelium: demonstration of defects in thymic epithelium structure and ganglioside expression in severe combined immunodeficiency disease (Abstract). Clin. Res.30: 350 (1982).Google Scholar
  36. 36.
    Colle, E.; Guttmann, R.D.; Seemayer, T.: Spontaneous diabetes mellitus syndrome in the rat. J. exp. Med.154: 1237–1242 (1981).PubMedCrossRefGoogle Scholar
  37. 37.
    Colle, E.; Guttmann, R.D.; Michel, F.; Seemayer, T.A.: Genetics of T lymphopenia in the syndrome of spontaneous diabetes mellitus in the rat (Abstract). Diabetes31: suppl. 2, p. 46 (1982).Google Scholar
  38. 38.
    LeCompte, P.M.: ‘Tnsulitis’ in early juvenile diabetes. Archs Path.66: 450–457 (1958).Google Scholar
  39. 39.
    Gepts, W.: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes14: 619–633 (1965).PubMedGoogle Scholar
  40. 40.
    Eisenbarth, G.S.; Wilson, P.W.; Ward, F.; Buckley, C; Lebovitz. H.: The polyglandular failure syndrome: disease inheritance, HLA type, and immune function. Ann. intern. Med.91: 528–533 (1979).PubMedGoogle Scholar
  41. 41.
    Nerup, J.; Andersen, O.O.; Bendixen, G.; Egeberg, J.; Poulsen, J.E.: Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes20: 424–427 (1971).PubMedGoogle Scholar
  42. 42.
    Nerup, J.; Andersen, O.O.; Bendixen, G.; Egeberg, J.; Poulsen, J.E.; Anti-pancreatic, cellular hyper- sensitivity in diabetes mellitus. Antigenic activity of fetal calf pancreas and correlation with clinical type of diabetes. Acta allerg.28: 223–230 (1973).Google Scholar
  43. 43.
    MacCuish, A.C.; Jordan, J.; Campbell, C.J.; Duncan, L.J.P.; Irvine, W.J.: Cell-mediated immunity to human pancreas in diabetes mellitus. Diabetes25:693–697(1974).Google Scholar
  44. 44.
    Nagaoka, K.; Sakurami, T.; Nabeya, N.; Imura, H.; Kuno, S.: The leucocyte migration inhibition test and subpopulations of peripheral lymphocytes in insulin-dependent diabetics. Endocr. jap.26: 89–95(1979).Google Scholar
  45. 45.
    Irvine, W.J.; MacCuish, A.C.; Campbell, C.J.; Duncan, L.J.P.: Organ-specific cell-mediated autoimmunity in diabetes mellitus. Acta endocr., suppl. 205, pp. 65–75 (1976).Google Scholar
  46. 46.
    Huang, S.-W.; MacLaren, N.K.: Insulin-dependent diabetes: a disease of autoaggression. Science192:64–66 (1976).PubMedCrossRefGoogle Scholar
  47. 47.
    Scott, J.; Daniels, J.C.; Poffenbarger, P.L.: In vitro cell-mediated cytolysis of intact islets of Langerhans in a study of type I diabetics (Abstract). Diabetologia21: 78–79 (1981).CrossRefGoogle Scholar
  48. 48.
    Boitard, C; Debray-Sachs, M.; Pouplard, A.; Assan, R.; Hamburger, J.: Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia21:41–46 (1981).PubMedGoogle Scholar
  49. 49.
    Kaldany, A.; Hill, T.; Wentworth, S.; Brink, S.J.; Delia, J.A.; Clouse, M.; Soeldner, J.S.: Trapping of peripheral blood lymphocytes in the pancreas of patients with acute-onset insulin-dependent diabetes mellitus. Diabetes31: 463–466 (1982).PubMedCrossRefGoogle Scholar
  50. 50.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Passive transfer of diabetes mellitus from man to mouse. Lanceti: 908–910 (1978).CrossRefGoogle Scholar
  51. 51.
    Neufeld, M.; McLaughlin, J.; MacLaren, N.K.; Rosenbloon, E.; Donnelly, W.: Failure to transfer diabetes mellitus from man to mouse. New Engl. J. Med.301: 665 (1979).PubMedGoogle Scholar
  52. 52.
    Lipsick, J.; Beattie, G.; Osier, A.G.; Kaplan, N.O.: Letter to the editor. Lanceti: 1290–1291 (1979).CrossRefGoogle Scholar
  53. 53.
    Thurneyssen, O.; Jansen, F.K.; Vialettes, B.; Vague, P.; Selam, J.L.; Mirouze, J.: Letter to the editor. Lanceti: 1291–1292 (1979).Google Scholar
  54. 54.
    Serra, A.S.; Farndon, J.R.; Shenton, B.K.; Johnston, I.D.A.: Letter to the editor. Lanceti: 1292 (1979).Google Scholar
  55. 55.
    Buschard, K.; Rygaard, J.; Madsbad, S.: Letter to the editor. Lancetii: 303 (1979).CrossRefGoogle Scholar
  56. 56.
    Beattie, G.; Lannom, R.; Lipsick, J.; Kaplan, N.O.; Osier, A.G.: Streptozotocin-induced diabetes in athymic and conventional BALB/c mice. Diabetes29: 146–150 (1980).PubMedCrossRefGoogle Scholar
  57. 57.
    Buschard, K.; Rygaard, J.: Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Acta pathol. microbiol. scand., C, Immunol.85: 469–472 (1977).Google Scholar
  58. 58.
    Kiesel, U.; Freytag, G.; Biener, J.; Kolb, H.: Transfer of experimental autoimmune insulitis by spleen cells in mice. Diabetologia19: 516–520 (1980).PubMedCrossRefGoogle Scholar
  59. 59.
    Paik, S.-G.; Fleischer, N.; Shin, S.-L.: Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc. natn. Acad. Sci. USA77: 6129–6133 (1980).CrossRefGoogle Scholar
  60. 60.
    Buschard. K.; Rygaard, J.: T-lymphocytes transfer streptozotocin induced diabetes mellitus in mice. Acta pathol. microbiol. scand., C, Immunol.86: 277–282 (1978).Google Scholar
  61. 61.
    Rossini. A.A.; Williams, R.M.; Appel, M.C.; Like, A.A.: Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature276: 182–184 (1978).PubMedCrossRefGoogle Scholar
  62. 62.
    Buschard, K.; Rygaard, J.; Lund, E.: The inability of a diabetogenic virus to induce diabetes mellitus in athymic (nude) mice. Acta pathol. microbiol. scand.. C Immunol.84: 299–303 (1976).Google Scholar
  63. 63.
    Paik, S.-G.; Yoon, J.-W.; Shin, S.: Induction of diabetes in mice by EMC virus: host T cells are not required (Abstract). Diabetes31: suppl. 2, p. 66 (1982).Google Scholar
  64. 64.
    Jansen. F.K.: Muntefering, H.; Schmidt, W.A.K.: Virus induced diabetes and the immune system. Diabetologia13: 545–549 (1977).PubMedCrossRefGoogle Scholar
  65. 65.
    Onodera, T.; Ray, U.R.; Melez, K.A.; Suzuki, H.; Toniolo, A.; Notkins, A.L.: Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature297:66–68 (1982).PubMedCrossRefGoogle Scholar
  66. 66.
    Ambinder, J.M.; Chiorazzi, N.; Gibofsky, A.; Fotino, M.; Kunkel. H.G.: Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin. Immunol. Immunopathol.23: 269–274 (1982).PubMedCrossRefGoogle Scholar
  67. 67.
    Jackson, R.A.; Morris, M.A.; Haynes, B.F.; Eisen-barth, G.S.: Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. New Engl. J. Med.306: 785–788 (1982).PubMedGoogle Scholar
  68. 68.
    Pozzilli, P.: Sensi, M.; Gorsuch, A.; Bottazzo, G.F.; Cudworth, A.G.: Evidence for raised K-cell levels in type I diabetes. Lancetii: 173–175 (1979).CrossRefGoogle Scholar
  69. 69.
    Pozzilli, P.; Sensi, M.; Dean, B.; Gorsuch, A.; Cudworth, A.: The importance of measuring Fc+ (killer) cells in insulin-dependent (type I) diabetes. Acta diabet. lat.17: 119–122 (1980).CrossRefGoogle Scholar
  70. 70.
    Sensi, M; Pozzilli, P.; Gorsuch, A.N.; Bottazzo, G.F.; Cudworth, A.G.: Increased killer cell activity in insulin dependent (type I) diabetes mellitus. Diabetologia20: 106–109 (1981).PubMedCrossRefGoogle Scholar
  71. 71.
    Sensi, M.; Pozzilli, P.; Cudworth, A.G.: Antibody-dependent and natural killer cytotoxicity in type I diabetes. Acta diabet. lat.18: 339–344 (1981).CrossRefGoogle Scholar
  72. 72.
    Ludwig, H.; Schernthaner, G.; Kraft, D.; Scheiner, O.; Mayr, W.R.: Antibody-dependent killer-cell function in insulin-dependent diabetes mellitus. J. endocrinol. Invest.3: 39–44 (1980).PubMedGoogle Scholar
  73. 73.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Depressed suppressor cell activity in patients with newly diagnosed insulin-dependent diabetes mellitus. Clin. exp. Immunol.41: 25–32 (1980).PubMedGoogle Scholar
  74. 74.
    Fairchild, R.S.; Kynder, J.L.; Abdou, N.I.: Specific immunoregulation abnormality in insulin-dependent diabetes mellitus. J. Lab. clin. Med.99: 175–186 (1982).PubMedGoogle Scholar
  75. 75.
    Galluzzo, A.; Giordano, C; Sparacino, G.; Bom-piani, G.D.; McNally, J.; Bottazzo, G.F.: Studies on suppressor cell function in the families of patients with insulin dependent diabetes mellitus (Abstract). Diabetologia21: 82 (1981).Google Scholar
  76. 76.
    Jaworski, M.A.; Guttman, R.D.; Colle, E.: Familial abnormalities of suppressor T cell activity in juvenile-onset insulin-dependent diabetes mellitus (Abstract). Clin. Res.30: 395 (1982).Google Scholar
  77. 77.
    Buschard, K.; Madsbad, S.; Rygaard, J.: Suppressor cell activity and beta-cell function in insulin-dependent diabetes. Acta pathol. microbiol. scand., C, Immunol.90: 53–57 (1982).Google Scholar
  78. 78.
    Buschard, K.; Madsbad, S.; Krarup, T.; Rygaard, J.: Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus. Clin. exp. Immunol.48: 189–195 (1982).PubMedGoogle Scholar
  79. 79.
    Lederman, M.M.; Ellner, J.J.; Rodman, H.M.: Defective suppressor cell generation in juvenile onset diabetes. J. Immun.127: 2051–2055 (1981).PubMedGoogle Scholar
  80. 80.
    Serjeantson, S.; Theophilus, J.; Zimmet, P.; Court, J.; Crossley, J.R.; Elliott, R.B.: Lymphocytotoxic antibodies and histocompatibility antigens in juvenile-onset diabetes mellitus. Diabetes30: 26–29 (1981).PubMedCrossRefGoogle Scholar
  81. 81.
    Sakane, T.; Steinberg, A.D.; Reeves, J.P.; Green, I.: Studies of immune functions of patients with systemic lupus erythematosus. J. clin. Invest.64: 1260–1269(1978).CrossRefGoogle Scholar
  82. 82.
    Srikanta, S.; Ganda, O.; Soeldner, S.; Eisenbarth, G.: Unpublished observations.Google Scholar
  83. 83.
    Gorsuch, A.N.; Spencer, K.M.; Lister, J.; McNally, J.M.; Dean, B.M.; Bottazzo, G.F.; Cudworth, A.G.: Evidence of a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancetii: 1363–1365 (1981).CrossRefGoogle Scholar
  84. 84.
    Elliott, R.B.; Crossley, J.R.; Berryman, C.C.; James, A.G.: Partial preservation of pancreatic β-cell function in children with diabetes. Lancetii: 1–4(1981).CrossRefGoogle Scholar
  85. 85.
    Deckert, T., Poulson, J.; Larsen, M.: The prognosis of insulin dependent diabetes mellitus and the importance of supervision. Acta med. scand., suppl. 624, pp. 48–53 (1979).Google Scholar

Copyright information

© Humana Press Inc. 1982

Authors and Affiliations

  • John B. Buse
    • 1
  • Richard F. Rowley
    • 1
  • George S. Eisenbarth
    • 1
  1. 1.Research DivisionJoslin Diabetes Center, Inc.Boston(USA)

Personalised recommendations